Breast Cancer - StoryMD
By A Mystery Man Writer
Description
Breast cancer is a cancer that starts in breast tissue. It happens when cells in the breast change and grow out of control. The cells usually form a tumor. Breast cancer is the second most common type of cancer in women in the United States. Rarely, it can also affect men.
![Breast Cancer - StoryMD](https://media.assettype.com/soulivity%2F2024-02%2F14ef21b7-3e31-4d3d-ac6d-df14acc4fb2b%2Foriginal.jpg?w=480&auto=format%2Ccompress&fit=max)
storymd
![Breast Cancer - StoryMD](https://cdn.storymd.com/optimized/pA723J3Fyq/thumbnail.jpg)
Quick Facts on Metastatic Breast Cancer - StoryMD
![Breast Cancer - StoryMD](https://cdn.storymd.com/optimized/8dnb2x7Hvd/thumbnail.webp)
The ABCs of Breast Cancer: Understanding the Different Types - StoryMD
![Breast Cancer - StoryMD](https://openstreetmap.hgw-prod.aws.healthgrades.zone/osm/14/4535/6431.png)
Dr. Hunter Story, MD: Psychiatrist - Winston Salem, NC - Medical
![Breast Cancer - StoryMD](https://cdn.storymd.com/optimized/pA75jxhld9/original.jpg)
Hereditary Breast Cancer and BRCA Genes - StoryMD
![Breast Cancer - StoryMD](https://cdn.storymd.com/optimized/yOoYWXUMqG/thumbnail.webp)
Surgery to Treat Breast Cancer - StoryMD
![Breast Cancer - StoryMD](https://cdn.storymd.com/optimized/Oo53xNFDqK/original.jpg)
Breast Cancer - StoryMD
![Breast Cancer - StoryMD](https://cdn.storymd.com/optimized/Qd94n7OH2o/thumbnail.jpg)
Pembrolizumab Improves Survival in Advanced Triple-Negative Breast
![Breast Cancer - StoryMD](https://pbs.twimg.com/media/FrLcpozWcAIbgPV.jpg)
Alexander Tsiaras (@atsiaras) / X
![Breast Cancer - StoryMD](https://cdn.storymd.com/optimized/RA8LmwPCZA/thumbnail.jpg)
Related HealthJournals - Metastatic Breast Cancer - StoryMD
![Breast Cancer - StoryMD](https://cdn.storymd.com/optimized/YqGDL6xf1A/thumbnail.webp)
Breast Cancer: Are You at Risk? - StoryMD
![Breast Cancer - StoryMD](https://www.hallwang-clinic.com/sites/default/files/styles/header-mobil/public/bg-breast-cancer-mobil.jpg?itok=0fGg3amy)
Individualizing Early-Stage HER2-Positive Breast Cancer
from
per adult (price varies by group size)